Angiogenesis inhibitors and their therapeutic potentials.
Yihai
Cao
C
Microbiology and Tumor Biology Center, Karolinska Institutet, S-171 77 Stockholm, Sweden. yihai.cao@mtc.ki.se
D000284:Administration, Oral; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D043168:Angiostatins / Q000378:metabolism; D000818:Animals; D019281:Dimerization; D018450:Disease Progression; D006801:Humans; D008954:Models, Biological; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy; D009389:Neovascularization, Pathologic; D000072483:Placenta Growth Factor; D011257:Pregnancy Proteins / Q000737:chemistry; D042461:Vascular Endothelial Growth Factor A / Q000737:chemistry
D020533:Angiogenesis Inhibitors; C000608036:PGF protein, human; D011257:Pregnancy Proteins; D042461:Vascular Endothelial Growth Factor A; D000072483:Placenta Growth Factor; D043168:Angiostatins